Cargando…
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors—Need for a Conductor
SIMPLE SUMMARY: Pancreatic neuroendocrine tumors (pNET) are a heterogeneous and challenging entity, and today’s guidelines offer a variety of treatment modalities, while surgery has a clear role for patients with resectable tumors and early stages, advanced, or metastatic pNET may benefit from treat...
Autores principales: | Siebenhüner, Alexander R., Langheinrich, Melanie, Friemel, Juliane, Schaefer, Niklaus, Eshmuminov, Dilmurodjon, Lehmann, Kuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946777/ https://www.ncbi.nlm.nih.gov/pubmed/35326628 http://dx.doi.org/10.3390/cancers14061478 |
Ejemplares similares
-
ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal
por: Eshmuminov, Dilmurodjon, et al.
Publicado: (2023) -
Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology
por: Valletti, Massimiliano, et al.
Publicado: (2021) -
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPEC
por: Roth, Lilian, et al.
Publicado: (2023) -
Orchestrating mitochondria in neurons: Cytoskeleton as the conductor
por: Cardanho‐Ramos, Carlos, et al.
Publicado: (2019) -
(18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study
por: Schneider, Paul M., et al.
Publicado: (2018)